QA: Inmed Pharmaceuticals Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001728328_2024_Inmed_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001728328, Inmed Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 11,331,727
1 IntangibleAssetsNetIncludingGoodwill 1,946,279
2 PropertyPlantAndEquipmentNet 723,426
3 remainder_Assets 104,908
4 LiabilitiesCurrent 2,000,619
5 LiabilitiesNoncurrent 15,994
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 13,665,701
8 SellingGeneralAndAdministrativeExpense 5,489,862
9 ResearchAndDevelopmentExpense 4,509,884
10 remainder_Expenses 4,558,988
11 remainder_Revenues 19,357,149
12 remainder_NetIncome 380,718
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,106,340
1 Liabilities 2,016,613
2 Expenses 28,224,435
3 Revenues 19,357,149
4 StockholdersEquity 12,089,727
5 NetIncome -8,486,568
6 ComprehensiveNetIncome -8,486,568
7 BaseVar 32,042,628
8 EconomicCapitalRatiobeforeLimitedLiability 2.22
9 EconomicCapitalRatio 3.17

Edgar->Model Mapping

Feature Distribution

Change over Time